H2

H2 EBITDA per Share

The EBITDA per Share of H2 (7851.TWO) as of Oct 22, 2026 is -2.27 TWD. In the previous year, EBITDA per Share was -2.15 TWD — a change of 5.65% (lower).

EBITDA per Share

-2.27TWD

YoY

5.65%

Last updated:

EBITDA per Share of H2 is 2024 -2.27 TWD. EBITDA per Share of H2 was 2023 -2.15 TWD. It decreases by 5.65% lower compared to the previous year.

The H2 EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2023
-2.15 TWD
Jan 1, 2024
-2.27 TWD
The H2 EBITDA per Share history
YEAREBITDA per ShareYoY
-2.27TWD+5.65%
-2.15TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

H2 Stock analysis

What does H2 do? H2 Inc generates revenue through its Health2Sync App, which offers a premium membership providing deeper analysis of health readings and educational content. The Patient Management Platform is sold to healthcare providers for patient prioritization and data-driven insights. Data Syncing supports integration with blood glucose meters, blood pressure monitors, weight scales, insulin pens, and CGMs, enabling seamless data import from various devices. The company serves healthcare providers, patients managing chronic conditions, and partners offering care services. Health2Sync App targets patients seeking daily management of chronic diseases through mobile and digital therapeutics, with features like tracking trends and receiving reminders. Premium members access advanced analytics and educational resources. The Patient Management Platform caters to healthcare organizations needing instant platform deployment and improved communication tools. Data Syncing facilitates connectivity with supported devices including CGM and insulin pen apps, enhancing user experience across the ecosystem. The company monetizes through subscription-based premium memberships for individual users and licensing fees for the Patient Management Platform to healthcare institutions. Data Syncing is integrated into the core product suite, driving adoption through device compatibility. Healthcare providers, chronic disease patients, and care partners form the primary customer segments purchasing these solutions. H2 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H2 stock

EBITDA per Share of H2 is -2.27 TWD in 2024.

EBITDA per Share of H2 changed from -2.15 TWD to -2.27 TWD, representing a 5.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share H2 since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — H2

All Key Metrics — H2